ข่าวประชาสัมพันธ์ Press Releases ข่าวย้อนหลัง หัวข้อข่าว บลอก

วันพุธที่ ๑๗ ตุลาคม พ.ศ. ๒๕๖๑ ๑๙:๔๕ น.

Food and Healthcare Press Releases

Samitivej warns more Thais at risk of food allergies Failure to get treatment can cause a life-threatening reaction Heathcare—๑๑ ต.ค. ๖๑

According to Samitivej Allergy Institute, the number of Thais at risk from food allergies has surged by 300-400 percent in recent years as a result of lifestyle changes. The risk factors come from good living and more awareness of cleanliness, which have

Doctors Talk: Tips to Recover from Training and Competition Like a Pro Athlete By Dr. Korakod Panich (M.D.), Herbalife Nutrition Advisory Board (NAB) Member Heathcare—๑๑ ต.ค. ๖๑

Doctor's Talk: Tips to Recover from Training and Competition Like a Pro Athlete By Dr. Korakod Panich (M.D.), Herbalife Nutrition Advisory Board (NAB) Member Have you ever felt that you have been exercising forever without getting anywhere near your

Herbalife Nutrition Launches Healthy Lifestyle Tips on Facebook Heathcare—๑๐ ต.ค. ๖๑

Herbalife Nutrition, a premier global nutrition company, is launching a social media campaign to promote a healthier and happier life. Health enthusiasts can benefit from 30 innovative nutrition ideas, tips, recipes, games and more, for overall

Herbalife Nutrition Survey Reveals Secrets to Healthy Aging, Announces Wellness Tour to Kickstart Heathcare—๑๖ ต.ค. ๖๑

As a company whose purpose is to make the world healthier and happier, premier global nutrition company, Herbalife Nutrition, today released findings from its 2018 Asia Pacific Healthy Aging Survey. Conducted in August 2018 with 5,500 respondents aged 40

Global Survey and Documentary Film Expose Emotional Impact of Multiple Heathcare—๑๒ ต.ค. ๖๑

- Merck-sponsored survey developed in collaboration with IACO and Eurocarers reveals lifelong effects of caring for a loved one with MS - #MSInsideOut documentary film, executively produced by Shift.ms, provides artistic take on the experiences of those

The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Heathcare—๑๑ ต.ค. ๖๑

Expands on existing commercial and co-development agreement for delafloxacin Consolidates company's strategic focus on infectious diseasesThe Menarini Group, an Italian biopharmaceutical company present in 136 countries worldwide, and Melinta

Exosystems to conduct trial run of new ICT rehabilitation solution in Heathcare—๑๑ ต.ค. ๖๑

The healthcare robotics company Exosystems will soon be conducting a trial run of its ICT muscular rehabilitation solution "ExoRehab" at hospitals in Vietnam. Exosystems, a member company of the K-ICT Born2Global Centre, has signed a partnership

Conjoined Twins From Mali Given New Lease of Life at Sidra Medicine, Heathcare—๑๑ ต.ค. ๖๑

Doctors at Qatar's first specialist women's and children's hospital Sidra Medicine have successfully separated conjoined twins, marking a first for the country. The surgery establishes an alternative for patients who previously had limited choices for

Hamad Bin Khalifa University#s Qatar Biomedical Research Institute Forms New Partnership With Heathcare—๙ ต.ค. ๖๑

Qatar Biomedical Research Institute (QBRI), a premier research institute under Hamad Bin Khalifa University (HBKU), has signed a collaborative research and training agreement with the Harvard Stem Cell Institute (HSCI) in Boston, USA. The five-year

Merck Data at ESMO 2018 Congress Highlight Multiple Therapeutics with Potential to Transform Cancer Heathcare—๙ ต.ค. ๖๑

Avelumab: LBA6_PR, 659P, 1290P, 1291P, 1282P, 877P; M7824 (TGF β-trap/anti-PD-L1):1048O, 1463P, 1931P, 757P, 643P, 642P, 661P; tepotinib (MET kinase inhibitor): 1377O, 621PD, 698P; M6620: 1437P; M3814: 1845P; M7583: 1014PD; abituzumab: 487P;

72% Say Policy-Making Should Be Open to Dialogue With Business: New European Research Commissioned Heathcare—๙ ต.ค. ๖๑

As the eighth session of the Conference of the Parties (COP8) to the World Health Organization (WHO) Framework Convention on Tobacco Control (FCTC) just closed in Geneva, new research commissioned by JTI and conducted in Europe by Populus with Ipsos as

Launch of The 4Klear(TM), Native 4K Surgical Microscope Camera with integrated 4K Heathcare—๕ ต.ค. ๖๑

Med X Change, Inc, (CEO: Seth Kardos) today announced the launch and Production availability* of the 4Klear, a 4K Camera & Medical Video Recorder All-In-One Solution for surgical microscopes (i.e. Leica Microsystems, Carl Zeiss Meditec, Haag-Streit

Merck Opens M Lab(TM) Collaboration Center in Sao Paulo, Brazil Heathcare—๕ ต.ค. ๖๑

- New collaboration center to provide support from pre-clinical through full-scale production in a non-GMP environment - Hands-on customer access to Merck's product portfolio, technical expertise Merck, the vibrant science and technology company, today

Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 (Topical Povidone-Iodine in Heathcare—๔ ต.ค. ๖๑

Veloce BioPharma Announces Positive Phase 2b Study Results for VBP-926 (Topical Povidone-Iodine in a Novel Non-Aqueous Vehicle) in Subjects with Chemotherapy-Associated Paronychia - Veloce BioPharma's VBP-926 (Povidone-Iodine) Demonstrates Statistically

Ryzodeg(R) Offers a Simpler Solution With Once-Daily Dosing and Reduced Risk of Nocturnal Heathcare—๒ ต.ค. ๖๑

When treated with once-daily Ryzodeg(R), people with type 2 diabetes achieved similar blood sugar control with half the number of daily injections, significantly lower total daily insulin dose and significantly reduced risk of nocturnal hypoglycaemia in

People With Diabetes May Achieve Improved Glycaemic Control With Tresiba(R) Versus Glargine U100, Heathcare—๒ ต.ค. ๖๑

According to results of a post-hoc analysis people with both type 1 and type 2 diabetes in clinical practice may achieve improved glycaemic control (HbA1c) with Tresiba(R) (insulin degludec) versus insulin glargine U100, without an increase in

Addressing Social and Cultural Drivers of Type 2 Diabetes is Key to Its Treatment and Heathcare—๒ ต.ค. ๖๑

New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffective, unless they address social and cultural factors.[1] Researchers linked factors such as food traditions and

งานเสวนา มะเร็งสู้ได้!!! ป้องกัน รักษาอย่างไรให้รอด Heathcare—๒ ต.ค. ๖๑

Assistant Administrator of Beijing Zhen-Guo Integrative Medicine Tumor Rehab Hospital (Beijing) 2) รศ.นพ.นรินทร์ วรวุฒิ อายุรศาสตร์มะเร็งวิทยา ประจำโรงพยาบาลชั้นนำหลายแห่ง สอบถามรายละเอียด / สำรองที่นั่ง Tel. 02-664-0079, Facebook :

Samitivej wins #The Most Improved Hospital in Thailand Award Heathcare—๒ ต.ค. ๖๑

Samitivej showcases dimensions of excellence with the latest achievement as a winner of The Most Improved Hospital in Thailand Award from the Asian Hospital Management Awards (AHMA). The hospital group is moving forward with a vision of "Organization of

HIMSS AsiaPac18 will Feature Best Practice from Global Militaries in the International Military Heathcare—๒ ต.ค. ๖๑

The HIMSS AsiaPac18 Conference and Exhibition will feature HIMSS' first-ever International Military Health Information Technology (IMHIT) track on 7 November. "HIMSS has received tremendous support from global militaries that are embarking on their

Owen Mumford Appoints Shirley Loh Regional Managing Director for Asia-Pacific Heathcare—๑ ต.ค. ๖๑

Owen Mumford, global industry leader in medical device design and manufacturing, has announced the appointment of Shirley Loh as Regional Managing Director for Asia-Pacific based at the company's Malaysian hub in Nusajaya. (Photo:

International Diabetes Federation (IDF) Global Survey Reveals 2 in 3 People With Type 2 Diabetes Heathcare—๒๘ ก.ย. ๖๑

- Cardiovascular disease (CVD) is the leading cause of disability and death in people with type 2 diabetes[1] - Despite the high incidence, 1 in 4 people with type 2 diabetes have never discussed, or cannot recall discussing, CVD risk factors with a

New Phase 2 Data for Somapacitan Demonstrate Its Potential as an Efficacious Once-weekly Treatment Heathcare—๒๘ ก.ย. ๖๑

Somapacitan, a novel growth hormone derivative in development for once-weekly administration of growth hormone, matched the therapeutic benefits of once-daily Norditropin(R) (somatropin) in a phase 2 trial in children with growth hormone deficiency.[1]

National Comprehensive Cancer Network Moves Global Headquarters to Plymouth Meeting, Heathcare—๒๘ ก.ย. ๖๑

- New location just outside Philadelphia will accommodate expanding operations devoted to improving cancer care worldwide Today, the National Comprehensive Cancer Network(R) (NCCN(R)) moved into new headquarters in Plymouth Meeting, PA, near